Potential CD34 signaling through phosphorylated-BAD in chemotherapy-resistant acute myeloid leukemia.

Acute myeloid leukemia (AML) constitutively express growth factors and cytokines for survival. Chemotherapy alters these signals to induce cell death. However, drug resistance in AML remains a major hindrance to successful treatment and early warning is unavailable.